Philip J. Clements

25.2k total citations · 2 hit papers
174 papers, 9.0k citations indexed

About

Philip J. Clements is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Philip J. Clements has authored 174 papers receiving a total of 9.0k indexed citations (citations by other indexed papers that have themselves been cited), including 122 papers in Pathology and Forensic Medicine, 68 papers in Pulmonary and Respiratory Medicine and 37 papers in Epidemiology. Recurrent topics in Philip J. Clements's work include Systemic Sclerosis and Related Diseases (119 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (56 papers) and Inflammatory Myopathies and Dermatomyositis (35 papers). Philip J. Clements is often cited by papers focused on Systemic Sclerosis and Related Diseases (119 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (56 papers) and Inflammatory Myopathies and Dermatomyositis (35 papers). Philip J. Clements collaborates with scholars based in United States, United Kingdom and Canada. Philip J. Clements's co-authors include Daniel E. Furst, Dinesh Khanna, Daniel E. Fürst, Donald P. Tashkin, Harold E. Paulus, Maureen D. Mayes, Peter A. Lachenbruch, Michael D. Roth, James R. Seibold and David Tak Yan Yu and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Philip J. Clements

170 papers receiving 8.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis.

1995 711 citations Philip J. Clements, Barbara White et al. PubMed profile →
Standardization of the Modified Rodnan Skin Score for Use in Clinical Trials of Systemic Sclerosis

2017 320 citations Dinesh Khanna, Daniel E. Furst et al. Journal of Scleroderma and Related Disorders profile →

Peers

Countries citing papers authored by Philip J. Clements

Since Specialization

Citations

This map shows the geographic impact of Philip J. Clements's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip J. Clements with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip J. Clements more than expected).

Fields of papers citing papers by Philip J. Clements

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip J. Clements. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip J. Clements. The network helps show where Philip J. Clements may publish in the future.

Co-authorship network of co-authors of Philip J. Clements

This figure shows the co-authorship network connecting the top 25 collaborators of Philip J. Clements. A scholar is included among the top collaborators of Philip J. Clements based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip J. Clements. Philip J. Clements is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Coping profiles and health outcomes among individuals with systemic sclerosis: A latent profile analysis approach	Journal of Scleroderma and Related Disorders	Scott C. Roesch, Philip J. Clements et al.	4
2	Reliability and Minimal Clinically Important Differences of FVC. Results from the Scleroderma Lung Studies (SLS-I and SLS-II)	American Journal of Respiratory and Critical Care Medicine	Suzanne Kafaja, Philip J. Clements et al.	86
3	Management of Widespread Skin Thickening in Diffuse Systemic Sclerosis	PubMed	Suzanne Kafaja, Philip J. Clements	4
4	Efficacy and Safety of Mycophenolate (MMF) Vs Oral Cyclophosphamide (CYC) for Treatment of Scleroderma-Interstitial Lung Disease (Ssc-ILD): Results of Scleroderma Lung Study II	CHEST Journal	Donald P. Tashkin, Michael D. Roth et al.	4
5	Articular involvement in systemic sclerosis	Lara D. Veeken	Jérôme Avouac, Philip J. Clements et al.	65
6	The pulmonary arterial hypertension quality enhancement research initiative: comparison of patients with idiopathic PAH to patients with systemic sclerosis-associated PAH	Annals of the Rheumatic Diseases	Philip J. Clements, Mary Tan et al.	54
7	Contemporary Trends in the Diagnosis and Management of PAH: An Initiative To Close the Care Gap	CHEST Journal	Vallerie V. McLaughlin, Anatoly Langer et al.	2
8	Tendon friction rubs in early diffuse systemic sclerosis: prevalence, characteristics and longitudinal changes in a randomized controlled trial	Lara D. Veeken	Puja Khanna, Daniel E. Fürst et al.	34
9	Systemic sclerosis and bilateral lung transplantation: a single centre experience	European Respiratory Journal	Rajeev Saggar, Dhanita Khanna et al.	66
10	Association of gastrointestinal involvement and depressive symptoms in patients with systemic sclerosis	Lara D. Veeken	Ron D. Hays, Paul Maranian et al.	65
11	Vitamin D, Parathyroid Hormone, and Acroosteolysis in Systemic Sclerosis	The Journal of Rheumatology	Yolanda Braun‐Moscovici, Daniel E. Furst et al.	51
12	A multicenter, randomized, double‐blind, placebo‐controlled trial of oral type I collagen treatment in patients with diffuse cutaneous systemic sclerosis: I. Oral type I collagen does not improve skin in all patients, but may improve skin in late‐phase disease	Arthritis & Rheumatism	Arnold E. Postlethwaite, Weng Kee Wong et al.	82
13	Bronchoalveolar Lavage and Response to Cyclophosphamide in Scleroderma Interstitial Lung Disease	American Journal of Respiratory and Critical Care Medicine	Charlie Strange, Marcy B. Bolster et al.	92
14	Reliability, validity, and minimally important differences of the SF-6D in systemic sclerosis	Quality of Life Research	Dinesh Khanna, Daniel E. Fürst et al.	47
15	Single-factor scoring validation for the Health Assessment Questionnaire-Disability Index (HAQ-DI) in patients with systemic sclerosis and comparison with early rheumatoid arthritis patients	Quality of Life Research	Jason C. Cole, Dinesh Khanna et al.	23
16	Systemic sclerosis (scleroderma) and related disorders: clinical aspects	Best Practice & Research Clinical Rheumatology	Philip J. Clements	44
17	Comparison of aminobenzoate potassium and placebo in the treatment of scleroderma.	PubMed	Daniel O. Clegg, James C. Reading et al.	13
18	Progressive retinal atrophy: a model for retinitis pigmentosa in companion animals.	PubMed	David R. Sargan, Philip J. Clements et al.	7
19	Home central venous hyperalimentation in fifteen patients with severe scleroderma bowel disease	Arthritis & Rheumatism	Swee Cheng Ng, Philip J. Clements et al.	31
20	Human lymphocyte subpopulations. Effect of corticosteroids.	Journal of Clinical Investigation	David Tak Yan Yu, Philip J. Clements et al.	245

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact